Difference between revisions of "Part:BBa K3110051"
| Line 17: | Line 17: | ||
<partinfo>BBa_K3110051 parameters</partinfo> | <partinfo>BBa_K3110051 parameters</partinfo> | ||
<!-- --> | <!-- --> | ||
| − | <h1>Usage and Biology<h1> | + | <h1>Usage and Biology</h1> |
The regulatory element lldR binds to the lldRO1 and lldRO2 (the operator regions) and inhibit transcription. J23117 is a promoter intercalated between the operators. lldR dimer represses the transcription possibly by forming a DNA loop which doesn’t allow the RNA polymerase to bind the promoter. Upon binding of L-Lactate to LldR, however, this transcriptional suppression is lost and instead lldR complex with L-Lactate remains bound to LldRO1 acting as a transcriptional activator. Interleukin-12. IL-12 is an anti-inflammatory cytokine, involved in the regulation of cell-mediated immune responses. Through a set of complex signaling cascade IL-12 activates our immune cells to reduce tumor growth. It is under the control of lactate sensitive O1PO2 to promote its production only when the cells encounter a thresold concentration of lactic acid. It is conjugated to YebF that mediates its secretion outside the cells into the cancer microenvironment. It also has a flag tag attached downstream to YebF so that its secretion outside the cells can be detected using anti-Flag antibodies. | The regulatory element lldR binds to the lldRO1 and lldRO2 (the operator regions) and inhibit transcription. J23117 is a promoter intercalated between the operators. lldR dimer represses the transcription possibly by forming a DNA loop which doesn’t allow the RNA polymerase to bind the promoter. Upon binding of L-Lactate to LldR, however, this transcriptional suppression is lost and instead lldR complex with L-Lactate remains bound to LldRO1 acting as a transcriptional activator. Interleukin-12. IL-12 is an anti-inflammatory cytokine, involved in the regulation of cell-mediated immune responses. Through a set of complex signaling cascade IL-12 activates our immune cells to reduce tumor growth. It is under the control of lactate sensitive O1PO2 to promote its production only when the cells encounter a thresold concentration of lactic acid. It is conjugated to YebF that mediates its secretion outside the cells into the cancer microenvironment. It also has a flag tag attached downstream to YebF so that its secretion outside the cells can be detected using anti-Flag antibodies. | ||
Revision as of 14:54, 20 October 2019
lldRO1-J23117-lldRO2 Strong RBS YebF-IL12
lldRO1 and lldRO2 are the operator regions which bind to the regulator element lldR and inhibit transcription. Upon binding of L-Lactate to lldR, however, this transcriptional suppression is lost and instead lldR complex with L-Lactate remains bound to lldRO1 acting as a transcriptional activator. By using RBS of different strengths we are trying to find out the optimum construct which will give output (in this case the output is YebF-IL12) that can efficiently discriminate cancer vs non-cancer micro-environments and will lead to secretion of IL12 (natural immuno-modulator) and eventually reduction of tumour size.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 78
Illegal NheI site found at 101 - 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Usage and Biology
The regulatory element lldR binds to the lldRO1 and lldRO2 (the operator regions) and inhibit transcription. J23117 is a promoter intercalated between the operators. lldR dimer represses the transcription possibly by forming a DNA loop which doesn’t allow the RNA polymerase to bind the promoter. Upon binding of L-Lactate to LldR, however, this transcriptional suppression is lost and instead lldR complex with L-Lactate remains bound to LldRO1 acting as a transcriptional activator. Interleukin-12. IL-12 is an anti-inflammatory cytokine, involved in the regulation of cell-mediated immune responses. Through a set of complex signaling cascade IL-12 activates our immune cells to reduce tumor growth. It is under the control of lactate sensitive O1PO2 to promote its production only when the cells encounter a thresold concentration of lactic acid. It is conjugated to YebF that mediates its secretion outside the cells into the cancer microenvironment. It also has a flag tag attached downstream to YebF so that its secretion outside the cells can be detected using anti-Flag antibodies.